Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

February 3, 2022

Impella® Transport Considerations

Adam Gottula, MD, discusses considerations for optimizing patient care when transporting patients supported with Impella or other mechanical circulatory support devices.

February 2, 2022

Using Administrative/Payer Databases: Limitations and Utility

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

January 24, 2022

Role of Echocardiography and Impella® in Cardiogenic Shock

Michael Galvin, BS, RDCS, discusses the role of echocardiography and Impella in cardiogenic shock.

December 7, 2021

Clinical Analysis of Impella® in High-Risk PCI

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

November 8, 2021

TCT 2021: Primary Results from the OPTIMUM Registry

Adam Salisbury, MD, presents the primary results from the OPTIMUM Registry, a late breaker at TCT 2021.

November 5, 2021

TCT 2021: SCAI Shock Stage Update

Srihari Naidu, MD discusses updates to the SCAI shock stages at TCT 2021.

November 4, 2021

TCT 2021: Real World Evidence Leading to RECOVER IV

William O’Neill, MD, discusses the development of best practices for treating AMI cardiogenic shock leading to the RECOVER IV RCT.

November 4, 2021

TCT 2021: MCS During High-Risk PCI and PROTECT IV

Gregg Stone, MD, reviews evidence for the use of mechanical circulatory support during high-risk PCI and provides an overview of the PROTECT IV RCT.

November 3, 2021

Best Practices for Treating High-Risk PCI Patients

Jason Wollmuth, MD, discusses large-bore access and intravascular imaging best practices for treating high-risk PCI patients.

November 3, 2021

Improved Outcomes with Contemporary Practices in PROTECT III

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

November 3, 2021

HFSA 2021: Identifying Patients for PROTECT IV

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

November 3, 2021

Protected PCI as a Practical Approach to MCS in Elective Complex Cases

William O’Neill, MD, discusses Protected PCI as a practical approach to mechanical circulatory support in elective complex PCI cases.

November 3, 2021

HFSA 2021: Management Considerations for HFCS

Jaime Hernandez-Montfort, MD, discusses management considerations for heart failure cardiogenic shock (HFCS) at HFSA 2021.

November 2, 2021

HFSA 2021: Clinical Evidence to Support ‘On-Pump’ Complex PCI in Heart Failure

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

November 1, 2021

HFSA 2021: Cardiogenic Shock Patients Can Achieve Heart Recovery

Shelley Hall, MD, discusses what can be done about cardiogenic shock and where the field is going, and issues a call for achieving heart recovery.

NPS-1674